BIRCH GROVE CAPITAL LP
Q1 2022 Form 13-F

NEW YORK, NEW YORK
CIK 0001652355 · CRD 168245 · SEC-registered investment adviser
$244.8M Reported Value Total

BIRCH GROVE CAPITAL LP reports 22 total accounts under management (AUM). There are 22 discretionary accounts valued at $3,802,409,924, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Exempt Reporting Adviser Discretionary Manager
Private funds (Form ADV)
12 funds · $4.8B gross asset value
Securitized Asset Fund: $3.6B · Hedge Fund: $1.1B · Private Equity Fund: $0
Source: Form ADV filed 2024-12-11
Reported value
$244.8M
Quarter over quarter
-5.1%
Holdings
15
Top-10 concentration
61.6%

Key People

Form ADV owners & control persons
Jonathan Israel Berger
LIMITED PARTNER
Andrew Adam Fink
LIMITED PARTNER
Todd Andrew Berry
CHIEF OPERATING OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2022 13F record

Q1 2022 13F filing summary

Q1 2022 Form 13F portfolio summary
Period of report March 31, 2022
Filed May 17, 2022
Form 13F-HR
Reported value $244.8M
Positions 15
Change in reported value +10.8%
New positions 8
Exited positions 17
Position turnover 78.1%
Top-10 concentration 61.6%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2024 13F
Filed Nov 14, 2024
0 $9.5M
Q2 2024 13F
Filed Aug 14, 2024
1 $10.0M
Q1 2024 13F
Filed May 15, 2024
2 $13.1M
Q4 2023 13F
Filed Feb 14, 2024
4 $23.3M
Q3 2023 13F
Filed Nov 14, 2023
5 $57.4M
Q2 2023 13F
Filed Aug 14, 2023
6 $68.1M
Q1 2023 13F
Filed May 15, 2023
6 $110.4M
Q4 2022 13F
Filed Feb 14, 2023
10 $210.1M
Q3 2022 13F
Filed Nov 14, 2022
12 $256.2M
Q2 2022 13F
Filed Aug 15, 2022
13 $251.9M
Q1 2022 13F
Filed May 17, 2022
15 $244.8M
Q4 2021 13F
Filed Feb 14, 2022
21 $220.9M
Q3 2021 13F
Filed Nov 15, 2021
21 $212.2M
Q2 2021 13F
Filed Aug 16, 2021
22 $205.8M
Q1 2021 13F
Filed May 17, 2021
28 $230.4M
Q4 2020 13F
Filed Feb 16, 2021
25 $191.7M
Q3 2020 13F
Filed Nov 16, 2020
31 $184.6M
Q2 2020 13F
Filed Aug 14, 2020
22 $120.6M
Q1 2020 13F
Filed May 15, 2020
5 $69.9M
Q4 2019 13F
Filed Feb 14, 2020
4 $80.7M

16 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2022

Largest Q1 2022 13F positions by reported value
# Holding Reported value % of portfolio
1 TRHC 1.75 02/15/26 TABULA RASA HEALTHCARE INC $22.9M 9.37%
2 KAMN 3.25 05/01/24 KAMAN CORP $17.5M 7.16%
3 HLF 2.625 03/15/24 HERBALIFE LTD $17.4M 7.11%
4 JAZZ 1.5 08/15/24 JAZZ INVESTMENTS I LTD $16.5M 6.76%
5 UBER 0 12/15/25 UBER TECHNOLOGIES INC $13.9M 5.67%
6 REAL 1 03/01/28 THE REALREAL INC $13.5M 5.52%
7 ENPH 0 03/01/26 ENPHASE ENERGY INC $12.9M 5.29%
8 SPLK 1.125 06/15/27 SPLUNK INC $12.5M 5.09%
9 SPOT 0 03/15/26 SPOTIFY USA INC $12.0M 4.89%
10 MGNI 0.25 03/15/26 MAGNITE INC $11.6M 4.73%
11 RNG 0 03/15/26 RINGCENTRAL INC $9.1M 3.71%
12 STRY STARR GROUP HOLDINGS INC $8.6M 3.53%
13 RDUS 3 09/01/24 RADIUS HEALTH INC $8.0M 3.28%
14 GMED 1 06/01/23 NUVASIVE INC $8.0M 3.26%
15 NOTV INOTIV INC $7.8M 3.17%
16 GMED 0.375 03/15/25 NUVASIVE INC $7.6M 3.11%
17 KPTI 3 10/15/25 KARYOPHARM THERAPEUTICS INC $7.5M 3.08%
18 SPLK 1.125 09/15/25 SPLUNK INC $7.2M 2.95%
19 AERI 1.5 10/01/24 AERIE PHARMACEUTICALS INC $7.2M 2.94%
20 DHT DHT HOLDINGS INC $2.9M 1.18%

Values as reported on the Q1 2022 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings